Cardiovascular and nonalcoholic fatty liver disease: Sharing common ground through SIRT1 pathways

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiology
• Hepatology

Background:

• Cardiovascular disorders are a leading cause of death globally.
• Nonalcoholic fatty liver disease (NAFLD) is a growing cause of liver disease, often co-occurring with metabolic disorders like diabetes mellitus (DM).
• Individuals with metabolic disorders have a significantly higher risk of cardiac, stroke, and liver diseases, including NAFLD.

Purpose of the Study:

• To explore the shared cellular mechanisms between cardiovascular disorders and NAFLD.
• To investigate the role of silent mating type information regulation 2 homolog 1 (SIRT1) in the pathology of these diseases.
• To assess the potential of targeting SIRT1 pathways for therapeutic interventions.

Main Methods:

• Review of existing literature on cardiovascular disease, NAFLD, and SIRT1.
• Analysis of the molecular pathways involving SIRT1, nicotinamide adenine dinucleotide, and associated factors.
• Exploration of SIRT1's role in cellular protection mechanisms.

Main Results:

• Cardiovascular disorders and NAFLD share SIRT1 as a common underlying cellular mechanism.
• SIRT1, a histone deacetylase, is implicated in metabolic pathways and cellular protection.
• SIRT1 influences trophic factors like erythropoietin, stem cells, and AMP-activated protein kinase.

Conclusions:

• SIRT1 pathways represent a potential therapeutic target for both cardiovascular and hepatic diseases.
• Further research into the complexity of SIRT1 pathways is crucial for developing effective clinical treatments.
• Targeting SIRT1 offers hope for managing these widespread non-communicable diseases.